SCHEMBL4879327

SCHEMBL4879327

COc1ccc(CN2C[C@@H]3C(c4ccc(NC(=O)OCc5ccccc5)cc4F)[C@@H]3C2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
TGM2 P21980 1/20 0.47
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
FAAH O00519 2/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
THRB P10828 1/20 0.45
RECQL P46063 1/20 0.45
MAPT P10636 3/20 0.44
KDM4E B2RXH2 1/20 0.44
HTT P42858 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.44
MGLL Q99685 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
BCHE P06276 2/20 0.43
ACHE P22303 2/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14197113 1.00 LMNA (0.48) LMNATGM2NPC1RAB9AFAAH
SCHEMBL5375022 0.90 LMNA (0.48) LMNATGM2NPC1RAB9AFAAH
SCHEMBL14370643 0.90 LMNA (0.48) LMNATGM2NPC1RAB9AFAAH
SCHEMBL14197151 0.87 LMNA (0.54) LMNATGM2NPC1RAB9AFAAH
SCHEMBL4884973 0.87 LMNA (0.54) LMNATGM2NPC1RAB9AFAAH
SCHEMBL14370613 0.82 MGLL (0.47) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL5375091 0.82 MGLL (0.47) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL14197111 0.80 TP53 (0.53) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL4882624 0.80 TP53 (0.53) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL2870132 0.79 USP30 (0.47) TGM2NPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES PFIZER INC 2008-04-17 US disclosed
US-7279494-B2 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues PFIZER INC. (US) 2007-10-09 US disclosed
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues RENSLO ADAM (US) 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues OXA1L, CYP51A1, CYP2C19 LMNA 3131/4885TGM2 3582/4885NPC1 682/4885
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES OXA1L, CYP51A1, CYP2C19 LMNA 2947/4885TGM2 3657/4885NPC1 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.